Drug Interaction Between Clopidogrel and Fluconazole

Mechanism of Interaction and Clinical Management

Fluconazole is a potent CYP2C19 inhibitor, which blocks the conversion of clopidogrel into its active metabolite, thereby reducing its antiplatelet efficacy and increasing the risk of thrombotic cardiovascular events, according to the Infectious Diseases Society of America 1
This interaction can reduce clopidogrel's effectiveness by approximately 25-30%, potentially leading to treatment failure in patients requiring antiplatelet therapy for acute coronary syndrome, recent stent placement, or stroke prevention, as reported by the Infectious Diseases Society of America 2

For invasive candidiasis, the Infectious Diseases Society of America recommends using an echinocandin instead of fluconazole, with options including micafungin, caspofungin, and anidulafungin 1, 2, 3
Lipid formulation amphotericin B is a second-line alternative for invasive candidiasis, with a recommended dose of 3-5 mg/kg daily, according to the Infectious Diseases Society of America 1, 2

For candidemia, the Infectious Diseases Society of America recommends standard doses of echinocandins, continued for 2 weeks after blood culture clearance and symptom resolution 1, 3
The Infectious Diseases Society of America prefers lipid formulations of amphotericin B over deoxycholate due to reduced nephrotoxicity, with a recommended dose of 3-5 mg/kg daily for invasive candidiasis 1, 2

For neutropenic patients, the Infectious Diseases Society of America recommends using echinocandins or lipid amphotericin B formulations over fluconazole, regardless of clopidogrel use 1, 2
For patients with recent azole exposure, the Infectious Diseases Society of America strongly prefers echinocandins to avoid resistance 1, 3